137 related articles for article (PubMed ID: 16168436)
1. Crystal structures of active SRC kinase domain complexes.
Breitenlechner CB; Kairies NA; Honold K; Scheiblich S; Koll H; Greiter E; Koch S; Schäfer W; Huber R; Engh RA
J Mol Biol; 2005 Oct; 353(2):222-31. PubMed ID: 16168436
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
Cowan-Jacob SW; Fendrich G; Manley PW; Jahnke W; Fabbro D; Liebetanz J; Meyer T
Structure; 2005 Jun; 13(6):861-71. PubMed ID: 15939018
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of the active and inactive states of Src kinase in solution by small-angle X-ray scattering.
Bernadó P; Pérez Y; Svergun DI; Pons M
J Mol Biol; 2008 Feb; 376(2):492-505. PubMed ID: 18164031
[TBL] [Abstract][Full Text] [Related]
5. Structure and regulation of Src family kinases.
Boggon TJ; Eck MJ
Oncogene; 2004 Oct; 23(48):7918-27. PubMed ID: 15489910
[TBL] [Abstract][Full Text] [Related]
6. Intertwined dimeric structure for the SH3 domain of the c-Src tyrosine kinase induced by polyethylene glycol binding.
Cámara-Artigas A; Martín-García JM; Morel B; Ruiz-Sanz J; Luque I
FEBS Lett; 2009 Feb; 583(4):749-53. PubMed ID: 19185573
[TBL] [Abstract][Full Text] [Related]
7. Structures of dimeric nonstandard nucleotide triphosphate pyrophosphatase from Pyrococcus horikoshii OT3: functional significance of interprotomer conformational changes.
Lokanath NK; Pampa KJ; Takio K; Kunishima N
J Mol Biol; 2008 Jan; 375(4):1013-25. PubMed ID: 18062990
[TBL] [Abstract][Full Text] [Related]
8. In silico activation of Src tyrosine kinase reveals the molecular basis for intramolecular autophosphorylation.
Mendieta J; Gago F
J Mol Graph Model; 2004 Oct; 23(2):189-98. PubMed ID: 15363460
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.
Krajewski WW; Collins R; Holmberg-Schiavone L; Jones TA; Karlberg T; Mowbray SL
J Mol Biol; 2008 Jan; 375(1):217-28. PubMed ID: 18005987
[TBL] [Abstract][Full Text] [Related]
10. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.
Knoechel TR; Tucker AD; Robinson CM; Phillips C; Taylor W; Bungay PJ; Kasten SA; Roche TE; Brown DG
Biochemistry; 2006 Jan; 45(2):402-15. PubMed ID: 16401071
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
Sack JS; Kish KF; Pokross M; Xie D; Duke GJ; Tredup JA; Kiefer SE; Newitt JA
Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):705-10. PubMed ID: 18566506
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of biotin protein ligase from Pyrococcus horikoshii OT3 and its complexes: structural basis of biotin activation.
Bagautdinov B; Kuroishi C; Sugahara M; Kunishima N
J Mol Biol; 2005 Oct; 353(2):322-33. PubMed ID: 16169557
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.
Muchmore SW; Smith RA; Stewart AO; Cowart MD; Gomtsyan A; Matulenko MA; Yu H; Severin JM; Bhagwat SS; Lee CH; Kowaluk EA; Jarvis MF; Jakob CL
J Med Chem; 2006 Nov; 49(23):6726-31. PubMed ID: 17154503
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site.
Jauch R; Jäkel S; Netter C; Schreiter K; Aicher B; Jäckle H; Wahl MC
Structure; 2005 Oct; 13(10):1559-68. PubMed ID: 16216586
[TBL] [Abstract][Full Text] [Related]
15. Structures of unliganded and inhibitor complexes of W168F, a Loop6 hinge mutant of Plasmodium falciparum triosephosphate isomerase: observation of an intermediate position of loop6.
Eaazhisai K; Balaram H; Balaram P; Murthy MR
J Mol Biol; 2004 Oct; 343(3):671-84. PubMed ID: 15465054
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for regulation of Src by the docking protein p130Cas.
Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
[TBL] [Abstract][Full Text] [Related]
17. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain.
Handa N; Takagi T; Saijo S; Kishishita S; Takaya D; Toyama M; Terada T; Shirouzu M; Suzuki A; Lee S; Yamauchi T; Okada-Iwabu M; Iwabu M; Kadowaki T; Minokoshi Y; Yokoyama S
Acta Crystallogr D Biol Crystallogr; 2011 May; 67(Pt 5):480-7. PubMed ID: 21543851
[TBL] [Abstract][Full Text] [Related]
19. E-novo: an automated workflow for efficient structure-based lead optimization.
Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state.
Williams NK; Lucet IS; Klinken SP; Ingley E; Rossjohn J
J Biol Chem; 2009 Jan; 284(1):284-291. PubMed ID: 18984583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
